Fomepizole

Drug Profile

Fomepizole

Alternative Names: 4-MP; Antizol; Fomepizole; Fomepizole Intravenous Infusion 1.5g "Takeda"

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer AFT Pharmaceuticals; Endo International; Jazz Pharmaceuticals plc; Takeda
  • Class Antidotes; Pyrazoles; Small molecules
  • Mechanism of Action Alcohol dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Methanol poisoning; Ethylene glycol poisoning
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Ethylene glycol poisoning; Methanol poisoning

Most Recent Events

  • 24 Apr 2017 Launched for Ethylene Glycol poisoning in Australia (IV)
  • 24 Apr 2017 Launched for Methanol poisoning in Australia (IV)
  • 27 Jan 2015 Launched for Ethylene Glycol poisoning in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top